Vision is precious, yet far too many people around the world live with vision impairment or blindness that could potentially be prevented or treated. (For a remarkable global resource, visit the IAPB Vision Atlas at https://visionatlas.iapb.org/, where you can explore the burden of vision impairment by country.)
Our research operates at the boundaries of mechanics, cell biology, and physiology to better understand the role of mechanics in disease, repair diseased tissues, and develop new treatments. In glaucoma, we conduct studies at the cellular level to reveal why intraocular pressure is elevated in this disease. In myopia, we investigate the molecular mechanisms responsible for triggering the abnormal eye growth that characterizes the condition. We also have a strong translational component: Dr. Ethier is co-founder of two early-stage biotechnology companies focused on treating glaucoma, including one based on a novel, mechanically-based strategy to achieve sustained lowering of intraocular pressure.
To learn more about our specific research areas, please follow the links below: